Panbio Pharm Llc Pharmaceutical Import Profile — Russia (DGFT 2022–2026)

Name: Panbio Pharm Llc Pharmaceutical Import Records from India — 5 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Panbio Pharm Llc — Pharmaceutical Importer Profile (2026) | 5 Products, $3.8M Trade | TransData Nexus

Panbio Pharm Llc

Pharmaceutical Importer · Russia · Nutritional Supplements Focus · $3.8M Total Trade · DGFT Verified

Panbio Pharm Llc is a pharmaceutical importer based in Russia with a total trade value of $3.8M across 5 products in 4 therapeutic categories. Based on 91 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Panbio Pharm Llc sources from 3 verified Indian suppliers, with Panacea Biotec Pharma Limited accounting for 75.0% of imports.

Panbio Pharm Llc — Import Portfolio & Supplier Network

Panbio Pharm Llc import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Panbio Pharm Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Panacea Biotec Pharma Limited	$5.0M	189	75.0%
Simpex Pharma Private Limited	$1.1M	71	16.7%
Micro Labs Limited

What Formulations Does Panbio Pharm Llc Import?

Formulation	Value	Ships
Kondro nova capsules (glucosamine	$363.5K	12
Alphadol ca capsules Each soft gelatincapsule contains alfacalcidol 0.25 MCG &calcium carbonate 500 MG equivalent	$158.1K	4
Alphadol capsules (Each soft gelatin	$150.0K	3
Kondro nova capsules glucosamine sulphate 250MG + chondroitin sulphate 200MG Each hard gelatin capsule contains	$150.0K	3
Kondro nova capusles glucosamine	$141.1K	4
Kondro nova capusles glucosamine sulphate 250 MG chonroitin sulphate 200MG Each hard gelatin CAPS cont	$141.1K	4
Nimulid suspension nimesulide	$132.1K	8
Nimulid nimesulide orodispersible	$112.7K	4
Nimulid nimesulide orodispersible tablets Each uncoated orodispersible tablets contains nimesulide BP....100 MG	$105.1K	3
Nimulid-1% gel for external	$100.0K	2
Nimulid nimesulide orodispersible tablets Each uncoated ordispersible tablets contains nimesulide BP....100 MG	$100.0K	2
Artrocare diacerein 50MG capsules 10x10s	$100.0K	2
Artrocare ( (diacerein 50MG capsules) )( 10x10s ) ( qty- 9634.000 )	$100.0K	2
Konro nova capsules (glucosamine	$97.6K	2
Nimulid tablets (Each tablet contains	$92.2K	2

Panbio Pharm Llc imports 165 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Glucosamine	Nutritional Supplements	$1.5M	35	11.2%	2
2	Calcium	Vitamins & Supplements	$1.3M	25	0.1%	15
3	Chondroitin	Nutritional Supplements	$683.4K	14	13.4%	2
4	Dextromethorphan	Respiratory & OTC	$250.0K	5	1.7%	10
5	Ornidazole	Advanced Antibiotics	$168.0K	12	1.0%	14

Panbio Pharm Llc imports 5 pharmaceutical products across 4 categories into Russia totaling $3.8M.

Panbio Pharm Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Panbio Pharm LLC is a Russian pharmaceutical importer and distributor specializing in the procurement and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2019, the company is headquartered in Reutov, Moscow Region, Russia. The legal address is 143960, Moscow Region, Reutov, Fabrichnaya Street, Building 8A, Room 14. (pbf.health) Panbio Pharm LLC plays a significant role in Russia's pharmaceutical supply chain by sourcing a diverse range of pharmaceutical products from international suppliers, particularly from India, to meet the domestic market's needs.

2Distribution Network

Panbio Pharm LLC operates a centralized distribution network with its primary warehouse located in Reutov, Moscow Region. This strategic location enables efficient logistics and distribution across Russia. The company has expanded its operations to include local production facilities, with plans to commence the production of painkillers and joint disease treatments in Reutov, enhancing its supply chain resilience and reducing dependency on imports.

3Industry Role

In Russia's pharmaceutical supply chain, Panbio Pharm LLC functions as a primary wholesaler and distributor. The company imports finished pharmaceutical formulations from international suppliers, particularly from India, and distributes these products to various stakeholders, including retail pharmacies, hospitals, and healthcare providers across Russia. By sourcing a wide array of pharmaceutical products, Panbio Pharm LLC ensures a steady supply of essential medications to meet the diverse needs of the Russian healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Panbio Pharm Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Panbio Pharm LLC demonstrates a high degree of supplier concentration, with 75% of its imports sourced from Panacea Biotec Pharma Limited, 16.7% from Simpex Pharma Private Limited, and 8.3% from Micro Labs Limited. This concentration indicates a strategic choice to establish strong partnerships with select suppliers, potentially ensuring consistent product quality and favorable terms. However, such dependency also poses risks, including supply chain disruptions if any of these suppliers face operational challenges. The company's decision to diversify its supplier base by including multiple suppliers from India suggests a proactive approach to mitigating these risks.

2Supply Chain Resilience

Panbio Pharm LLC's supply chain resilience is bolstered by its diversified sourcing strategy, engaging multiple suppliers from India. The company's plan to initiate local production in Reutov further enhances its supply chain stability by reducing reliance on international suppliers and mitigating potential disruptions. Additionally, the implementation of a customized CRM system developed by Sber Business Soft in June 2023 indicates a commitment to optimizing operations and improving responsiveness to market demands. (akm.ru)

3Strategic Implications

Importing Pharmaceuticals into Russia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Russia

1Regulatory Authority & Framework

In Russia, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) is the primary regulatory authority overseeing pharmaceutical imports and ensuring compliance with national standards. Key legislation governing pharmaceutical imports includes the Federal Law No. 61-FZ "On Circulation of Medicines," which outlines the requirements for importing, registering, and distributing pharmaceutical products in Russia. The marketing authorization pathway for Indian generics involves obtaining a Certificate of Pharmaceutical Product (COPP) from the exporting country, followed by registration with Roszdravnadzor, which includes submission of technical documentation, clinical trial data, and compliance with Good Manufacturing Practice (GMP) standards.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Russia necessitate that foreign manufacturers hold valid GMP certificates recognized by Roszdravnadzor. These certificates must be issued by competent authorities in the exporting country and demonstrate compliance with international GMP standards. Indian exporters seeking to supply Panbio Pharm LLC must ensure that their manufacturing facilities are GMP-compliant and that they possess the necessary certifications to facilitate the import process into Russia.

Panbio Pharm Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Panbio Pharm LLC's focus on importing nutritional supplements, vitamins, and respiratory OTC products aligns with the growing demand for preventive healthcare and wellness products in Russia. The company's portfolio strategy addresses prevalent health concerns, such as joint diseases and respiratory conditions, by sourcing products that offer therapeutic benefits and cater to the health-conscious consumer segment.

2Sourcing Profile

Panbio Pharm LLC's sourcing strategy emphasizes the procurement of generic drugs, particularly those with established efficacy and safety profiles. The company's preference for formulations that are well-suited to the Russian market, including those with appropriate dosage forms and packaging, reflects a strategic approach to meeting local consumer needs. India's robust pharmaceutical manufacturing capabilities and adherence to international quality standards make it a preferred sourcing partner for Panbio Pharm LLC.

3Market Positioning

Based on its product mix, Panbio Pharm LLC serves multiple segments of the Russian pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's diverse portfolio enables it to cater to a wide range of healthcare providers and consumers, positioning it as a versatile and reliable distributor in the Russian market.

Seller's Guide — How to Become a Supplier to Panbio Pharm Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Panbio Pharm LLC, particularly in supplying high-demand pharmaceutical products that align with the company's therapeutic focus areas. Gaps in Panbio Pharm LLC's current sourcing may exist in specialized formulations or emerging therapeutic areas, presenting opportunities for Indian exporters to introduce innovative products to the Russian market.

2Requirements & Qualifications

Indian exporters seeking to supply Panbio Pharm LLC and the Russian market must possess valid GMP certifications recognized by Roszdravnadzor, such as WHO-GMP or EU-GMP. They must also provide comprehensive technical documentation, including COPP, Certificate of Analysis (COA), stability data, batch records, and product formulas, to facilitate the import and registration process in Russia.

3How to Approach

To establish a relationship with Panbio Pharm LLC, Indian exporters should initiate contact through formal channels, presenting their product portfolios and demonstrating compliance with Russian regulatory requirements. Participating in industry trade fairs and conferences in Russia can also provide opportunities for direct engagement. Developing a clear regulatory filing strategy, including the preparation of necessary documentation and understanding of the registration process, is essential. Timelines for regulatory approval can vary; therefore, maintaining open communication with Panbio Pharm LLC and Russian regulatory authorities is crucial to ensure a smooth market entry.

Frequently Asked Questions — Panbio Pharm Llc

What products does Panbio Pharm Llc import from India?

Panbio Pharm Llc imports 5 pharmaceutical products across 4 categories. Top imports: Glucosamine ($1.5M), Calcium ($1.3M), Chondroitin ($683.4K), Dextromethorphan ($250.0K), Ornidazole ($168.0K).

Who supplies pharmaceuticals to Panbio Pharm Llc from India?

Panbio Pharm Llc sources from 3 verified Indian suppliers. The primary supplier is Panacea Biotec Pharma Limited (75.0% of imports, $5.0M).

What is Panbio Pharm Llc's total pharmaceutical import value?

Panbio Pharm Llc's total pharmaceutical import value from India is $3.8M, based on 91 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Panbio Pharm Llc focus on?

Panbio Pharm Llc imports across 4 categories. The largest: Nutritional Supplements (56.5%), Vitamins & Supplements (32.6%), Respiratory & OTC (6.5%).

Get Full Panbio Pharm Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.